ambrisentan and tadalafil combination therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ambrisentan and tadalafil combination therapy, covering 2015-04-28 to 2015-04-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 3]